Mode
Text Size
Log in / Sign up
N/A N=6 Treatment

Study of the Ability of Betaine Hydrochloride to Increase Stomach Acid in Healthy Volunteers

Pharmacodynamic

Enrolled (actual)
6
Serious AEs
0.0%
Results posted
Jul 2013
Primary outcome: Primary: Change in Gastric pH After Administration of Betaine Hydrochloride (HCl) — 4.54 units on a scale

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
betaine hydrochloride (Dietary_supplement); Rabeprazole (Drug)
Age
Adult · 18+ yrs
Sex
All
Sponsor
University of California, San Francisco
Primary completion
Jul 2011

Outcome Measures

OutcomeResultp-value
PRIMARY
Change in Gastric pH After Administration of Betaine Hydrochloride (HCl)
4.54
SECONDARY
Duration of Gastric pH Status
6.3; 72.5; 76.8

Summary

In this study the investigators will test a nutritional supplement called betaine hydrochloride to see if it can temporarily increase the stomach acid in healthy volunteers who have decreased stomach acid because they take a medicine called rabeprazole.

Eligibility Criteria

Inclusion Criteria

  • Healthy adult with no active medical problems or significant chronic diseases as determined by the study doctor based on history, physical exam;
  • BMI between 18.5 - 35 kg/m2;
  • Taking no medications 2 weeks before and during the study enrollment, including drugs of abuse, prescription or OTC medications (except acetaminophen);
  • Subjects must be able to maintain adequate birth control during the study independent of hormonal contraceptive use;
  • Be able to provide written informed consent and comply with requirements of the study;
  • Avoid eating grapefruit and drinking grapefruit juice from 7 days before the first study day until completion of the entire study;
  • Abstinence from alcoholic beverages, caffeinated beverages and orange juice from 6pm the night before a study day until completion of that study day;
  • Fast from food and beverages at least 8 hours prior to the study day;
  • Be able to read, speak and understand English

Exclusion Criteria

  • Subjects with a history of gastrointestinal disease including gastroesophageal reflux disease, gastritis, peptic ulcer disease or dyspepsia.
  • Subjects with a fasting gastric pH of > 4 (i.e. hypochlorhydria)
  • Subjects with history of dysphagia, achalasia, or difficulty swallowing capsules, tablets or pills.
  • Subjects on prescription or chronic over-the counter medications (including hormonal contraceptives);
  • Subjects with known allergy to study interventions;
  • Subjects who smoke tobacco;
  • Subjects with ongoing alcohol or illegal drug use;
  • Subjects who are pregnant, lactating or attempting to conceive;
  • Subjects unable to maintain adequate birth control during the study;
  • Subjects unable to follow protocol instructions or protocol criteria.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01237353). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search